Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Low Dose Urokinase Therapy in Patients With Diabetic Foot Syndrome and Critical Limb Ischemia Versus Conventional Standard Therapy

NCT00823225 is registered in ClinicalTrials.gov with medac GmbH as lead sponsor.

NCT NCT00823225
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00823225 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Low Dose Urokinase Therapy in Patients With Diabetic Foot Syndrome and Critical Limb Ischemia Versus Conventional Standard Therapy
Lead sponsor
medac GmbH
Phase
Phase 3
Overall status
Terminated
Start date
June 30, 2008
Completion date
June 30, 2009
Enrollment
5 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

arterial occlusive disease, diabetic foot, ischemia